Seeking Alpha
 

Nuance Communications, Inc. (NUAN)

- NASDAQ
  • Aug. 7, 2013, 2:32 PM
    • Nuance (NUAN -1.8%) is now down just slightly after providing soft FQ4 guidance (attributed to a sales shift towards recurring revenue) to go with an FQ3 beat.
    • Though lowering its PT to $23 from $25, Oppenheimer thinks 10%+ shareholder Carl Icahn could soon push for a sale of the company.
    • FBR (Market Perform) argues the voice recognition software/services leader is "well-positioned given good secular trends and a strong product cycle," but remains cautious on account of "execution issues and a painful transition to a subscription model."
    • Nuance mentioned on its CC hosting-based sales now make up 32% of revenue (30% a year ago), and that the estimated 3-year value of its on-demand contracts is up 11% Y/Y. Also, professional services backlog grew 35% Y/Y in FQ3, and the number of "unique connected devices" relying on Nuance's cloud services doubled.
    • CEO Paul Ricci admitted "transitions and execution issues" affected Nuance's guidance, and that the company recently replaced a senior manager in its European sales ops. Ricci also reiterated Nuance is willing to let mobile deals "be delayed for the sake of price discipline."
    | Comment!
  • Aug. 7, 2013, 9:14 AM
    | Comment!
  • Aug. 6, 2013, 4:54 PM
    • In prepared remarks, Nuance (NUAN) guides for FQ4 revenue of $470M-$500M and EPS of $0.24-$0.32, below a consensus of $519.8M and $0.38.
    • The company blames its shift to recurring/subscription-based revenue streams, which leads to lower up-front sales. Mobile/consumer is singled out as an area where the shift "has the effect of elongating revenue."
    • FQ3 healthcare sales +2% Y/Y (boosted by acquisitions), even with FQ2; division made up 55% of segment profit. Mobile/consumer sales slumped: revenue -19% vs. -2%. Enterprise improved: revenue +7% vs. -20% in FQ2. Imaging -4% vs. -10%.
    • Healthcare transcription sales still weak, Clintegrity and Dragon Medical stronger. 1.8B cloud mobile/consumer transactions in FQ3, +80% Y/Y. Enterprise lifted by demand for Nina voice assistant apps.
    • Deferred revenue balance (stems from subscriptions/recurring revenue) was $396.5M, +2% Q/Q and +32% Y/Y. Operating cash flow was $85.5M vs. $141.5M a year ago.
    • $115M spent on buybacks.
    • FQ3 results, PR
    | 4 Comments
  • Aug. 6, 2013, 4:04 PM
    • Nuance (NUAN): FQ3 EPS of $0.34 beats by $0.02.
    • Revenue of $490.8M (+9.5% Y/Y) beats by $3.2M.
    • Shares +3.6% AH. CC at 5PM ET (webcast). (PR)
    | Comment!
  • Apr. 30, 2013, 4:58 PM
    Nuance (NUAN -18.3%) +1.5% AH, recouping a small portion of today's huge post-earnings decline, after Carl Icahn discloses he has raised his stake in the company to 10.7% from a prior 9.3%. (13G) (Nuance FQ2: I, II)
    | Comment!
  • Apr. 30, 2013, 12:46 PM
    Midday top 10 gainers: TTHI +45%. PTIE +26%. DRRX +26%. MTOR +23%. MGAM +20%. OIS +16%. GIB +14%. HGSH +15%. ARWR +13%. TXRH +13%.
    Midday top 10 losers: DCTH -44%. AVEO -26%. NUAN -18%. AOSL -18%. PBI -16%. AEIS -13%. MSTR -10%. ANV -10%. ELTK -10%. SYN -10%.
    | Comment!
  • Apr. 30, 2013, 9:16 AM
    Nuance (NUAN) -13.7% following its FQ2 miss. In prepared remarks, the company guides for FQ3 revenue of $480M-$495M and EPS of $0.30-$0.34, below a consensus of $554.1M and $0.49. FY13 guidance is for revenue of $1.96B-$2B and EPS of $1.33-$1.45, below a consensus of $2.16B and $1.80. Preliminary FY14 guidance is for organic growth in the "mid- to upper-single digit range;" consensus is for revenue of $2.44B. Mobile & Consumer sales -4% Y/Y in FQ2 after rising 17% in FQ1, and Enterprise -20% vs. +10% in FQ1. Healthcare (over half of profits) +2% (+3% prior); Imaging -10% (+6% prior). Buyback currently good for repurchasing 7.8% of shares.
    | 1 Comment
  • Apr. 30, 2013, 9:10 AM
    Premarket gainers: HPY +10%. HTWR +9%. ANAD +9%. AVP +8%. UBS +7%. BBY +6%.
    Losers: DCTH -20%. AVEO -16%. NUAN -15%. PBI -10%. MTG -8%. CNH -6%. RVBD -6%. QGEN -5%.
    | Comment!
  • Apr. 24, 2013, 11:47 AM
    Nuance (NUAN +4.6%) spikes as Dow Jones reports the company has hired Goldman to help find a buyer - there was a rumor along these lines two weeks ago. If true, look for Carl Icahn to take an active interest in the proceedings. 11.8% of Nuance's float was shorted as of March 28, but that was before Icahn disclosed his 9.3% stake.
    | 1 Comment
  • Apr. 22, 2013, 10:35 AM
    Nuance (NUAN +2.9%) breaks $21 after announcing HTC Car, a navigation/infotainment/hands-free control app provided with HTC's flagship One smartphone, is powered by Nuance's voice recognition tech. The One has generally received glowing reviews. (PR) (AutoNavi deal)
    | Comment!
  • Apr. 9, 2013, 11:10 AM
    A rumor Nuance (NUAN +3.3%) has hired Goldman to explore strategic alternatives is fueling a rally in shares of the voice recognition giant. Needless to say, Carl Icahn's newfound interest in the company have much to do with investor hopes for a major payoff. 11% of the float was shorted as of March 15.
    | Comment!
  • Apr. 2, 2013, 9:10 AM
    Premarket gainers: BGCP +47%. OMPI +14%. HUM +10%. NUAN +9%. URBN +6%.
    Losers: NAT -12%. AFFY -7%.
    | Comment!
  • Apr. 1, 2013, 5:37 PM
    After-hours top gainers, as of 5:15 p.m.: BGCP +43%. HUM +9%. NUAN +6%. AMSC +6%. UNH +4%.
    After-hours top losers: NAT -6%. ATLS -3%. CECO -3%. SCVL -3%. IMN -2%.
    | 1 Comment
  • Apr. 1, 2013, 5:12 PM
    Nuance (NUAN) +9% AH on news Carl Icahn has amassed a 9.3% stake. Is Icahn looking to make an activist push? Nuance's acquisition-fueled growth strategy has received some criticism over the years.
    | 10 Comments
  • Feb. 8, 2013, 6:38 PM
    The Street showed no mercy to Nuance (NUAN -18.5%) in response to its EPS miss and forecast for multiple quarters of weakness in healthcare and EMEA sales. Goldman thinks Nuance's goal of $1B in FY13 healthcare sales is now at risk, and Needham (downgrading to Hold) is concerned about guidance for a 200-250 bps FY13 gross margin drop, worse than a prior forecast. Management suggested on the earnings call it's counting on clinical documentation software sales and PC/mobile OEM deals to drive future growth.
    | 3 Comments
  • Feb. 8, 2013, 1:00 PM
    Midday top 10 gainers: BDCO +32%. CZR +25%. ONCY +23%. LNKD +20%. SNCR +19%. GALT +13%. ZN +13%. FLT +12%. ZNGA +12%. ATVI +11%.
    Midday top 10 losers: ETRM -55%. MSON -22%. GUID -21%. NUAN -19%. RVBD -18%. QKLS -16%. JE -14%. NSP -13%. STS -11%. SPWR -10%.
    | Comment!
Visit Seeking Alpha's
NUAN vs. ETF Alternatives
Company Description
Nuance Communications Inc provides voice and language solutions for healthcare, mobile, consumer, enterprise customer service and imaging markets.
Sector: Technology
Country: United States